TLDR
- Daniel Ives from Wedbush established a record-breaking $350 price objective for Apple, suggesting approximately 34% growth potential while maintaining his Outperform recommendation
- The company’s refreshed Mac collection — featuring M5-equipped MacBook Air/Pro models plus the budget-friendly $599 MacBook Neo — could trigger a significant AI-powered replacement cycle
- Apple surpassed Q1 projections delivering $2.84 EPS (versus anticipated $2.67) and $143.76 billion revenue, representing 15.7% annual growth
- Oppenheimer Asset Management expanded its AAPL holdings by 9% during Q3, joining major institutional investors like Vanguard and State Street in increasing positions
- Analyst community maintains Moderate Buy outlook on AAPL with $306.12 mean price objective; shares began Friday trading at $260.29
Apple (AAPL) stock has captured renewed Wall Street interest following Wedbush’s announcement of a $350 price objective — representing the highest analyst target currently — as institutional capital continues flowing in and the tech giant delivers impressive quarterly performance.
On March 6, Wedbush’s Daniel Ives established this unprecedented Street-leading target while confirming his Outperform stance. Based on current trading levels near $260, this objective suggests potential appreciation of approximately 34%. Ives highlighted Apple’s broadening Mac product range, anchored by next-generation M5 processors, as a fundamental catalyst for an anticipated AI-driven hardware replacement wave.
The refreshed product portfolio features redesigned MacBook Air and MacBook Pro units powered by M5 processors delivering enhanced AI capabilities, accelerated memory performance, and extended battery longevity. Apple simultaneously unveiled the MacBook Neo, a 13-inch device priced from $599, strategically positioned for budget-oriented consumers and educational institutions.
Ives emphasized that approximately 50% of Mac purchasers currently represent platform newcomers — a statistic he interprets as confirmation that Apple is broadening market penetration beyond merely serving its established customer base.
Gene Munster alongside fellow analysts have suggested the MacBook Neo and iPhone 17e could generate supplementary revenue streams while enabling Apple to capture market share within entry-level and educational sectors. Wedbush characterized the diversified product spectrum, spanning premium AI-enabled laptops to affordable entry offerings, as a mechanism to unlock “incremental upside” across Mac revenues.
Quarterly Performance Exceeds Expectations
Apple’s latest quarterly disclosure, released January 29, provided additional momentum for optimistic investors. The technology leader delivered $2.84 earnings per share, surpassing consensus projections of $2.67 by $0.17. Total revenue reached $143.76 billion, exceeding analyst estimates of $138.25 billion while advancing 15.7% compared to the prior year.
Return on equity measured 159.94%, accompanied by a 27.04% net margin. Wall Street analysts currently project full-year earnings per share of $7.28 for the ongoing fiscal period.
The company distributed its quarterly dividend of $0.26 per share on February 12, translating to $1.04 annualized and yielding 0.4%.
Institutional Investment Continues Expanding
Oppenheimer Asset Management expanded its AAPL allocation by 9% throughout Q3, elevating its position to 362,318 shares valued near $92.26 million. AAPL currently comprises 1.0% of Oppenheimer’s aggregate portfolio, ranking as its 12th largest holding.
Major institutional players similarly increased their exposure. Vanguard expanded its Apple investment by 1.1% during Q2, while State Street augmented its position by 0.9%. Geode Capital Management boosted its stake by 1.4%. Norges Bank established a fresh position in Q2 valued at approximately $38.9 billion. Institutional ownership represents 67.73% of Apple’s total outstanding shares.
Broader Analyst Sentiment Remains Constructive
The wider analyst community displays predominantly favorable positioning though opinions vary. JPMorgan elevated its target from $315 to $325 alongside an Overweight designation. Scotiabank established a $330 objective. Goldman Sachs and Sanford C. Bernstein both maintain Buy or Outperform classifications.
MarketBeat’s compiled data indicates a $297.58 average target with “Moderate Buy” consensus — comprising 22 Buy recommendations, 12 Holds, and one Sell rating. TipRanks analysis places the average at $306.12 based upon 15 Buys, 9 Holds, and one Sell.
Shares commenced Friday trading at $260.29, within a 12-month trading range spanning $169.21 to $288.62. The 50-day moving average registers at $263.88, marginally above the 200-day average of $260.07.


